SOURCE: SNM Global Holdings

July 13, 2010 09:00 ET

SNM Global Biotech Portfolio Prepared as UN Launches Biotech Network for Developing Countries

LONDON--(Marketwire - July 13, 2010) -  SNM Global Holdings (PINKSHEETS: SNMN) announced the launch of its Biotech Initiatives to coincide with the recent launch by the United Nations Industrial Development Organization (UNIDO) of the International Industrial Biotechnology Network (IIBN).

Developing countries wanting to make more of their biotechnology resources are the target of a network launched by the United Nations.

George Tzotzos, IIBN programme coordinator, told SciDev.Net that the network would provide biotechnology support and access to high-level technologies for developing countries wanting to make better use of their existing biological resources.

The IIBN will help local universities and small-to-medium enterprises develop and improve existing biotechnology products. It will also encourage further bio-prospecting. Ivan Ingelbrecht, project manager for the IIBN and based at Ghent University, Belgium, said the network would serve as a catalyst for establishing North-South and South-South partnerships.

SNM Global's MicroTechnology Transfer (mt2) Program and MicroEquity Partner Program enables the acquisition, development, and transfer of technologies that will provide for the betterment of society and provide the catalyst for emerging markets to leapfrog into the sustainable sectors that will drive the twenty-first century. The newly acquired technologies and/or technology groups will be placed in the appropriate stage of the Company's MicroTechnology Transfer (mt2) Program and MicroEquity Partner Program.

In addition to its other vertical sectors, SNM Global Holdings provides international emerging markets with alternative energy, and decentralized power production technologies. The company also provides biotech and healthcare related assets and technology to these markets. The company believes its new and enhanced operational plan will provide significant revenue, equity growth, and serve the betterment of emerging economies.

SNM Global's MicroTechnology Transfer (mt2) Program is designed to further the commercialization of promising technologies that will benefit emerging markets in four key areas:

  • Energy -- Clean, Renewable, and Sustainable Energy
  • Health -- Better Health & Living
  • Water -- Drinking Water, Irrigation & Sanitation
  • Agriculture -- Green Biotechnology

The Company encourages collaboration with public, private and institutional partners in all phases of the development and technology transfer cycle; and accepts submissions from both collaborative development, distribution and inventor partners through the Collaboration Portal on its new website at

The company anticipates numerous technology and operational acquisitions and will continue to provide regular updates. The Company will soon announce additional details alongside full operational and financial disclosures.

About SNM Global Holdings

SNM Global Holdings (SNM Global) is a technology holding and development company that invests in, acquires, and develops Intellectual Property Assets and Operations in the Clean/Alternative Energy, Biotech, Water and Better Health & Living sectors adapted specifically for the emerging global markets.

The Company realizes revenues from the distribution of its technology, products, and solutions through its network of international agents and distributors and through the licensing of Intellectual Property through its innovative mt2 Program. The Company provides its International MicroEquity Partner program to our local partners in our target international markets. This program provides initial funding to a community building and life-enhancing organization. The Company sees profits through equity ownership and sales and distribution of its technology and solutions.

The company operates through its subsidiaries and various distribution partners worldwide. For more information, visit the company's website at:

Safe Harbor

This release contains statements or projections regarding future performance that is forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties. The company's filings contain various RISK FACTORS (and are incorporated on the Company's website "Investors" section by reference) and should be read before any investment decision.

Contact Information